Abstract

AMPA, NMDA and kainate receptors belong to the ionotropic glutamate receptor (iGluR) family. As binding to glutamate, a major fast excitatory neurotransmitter, causes activation of these channels, they play an important role in synaptic plasticity, memory and learning. Our research focuses on understanding how these receptors are regulated, for potential applications in conditions such as Alzheimer's and Parkinson's disease.The data presented here is aimed at understanding the differential regulation of NMDA receptors by the endogenous neurosteroids pregnenolone sulfate (PS) and 3‐alpha‐hydroxy‐5‐beta‐pregnan‐20‐one sulfate (PREGAS). PS potentiates the activity of NMDA receptors containing an NR2B subunit while it inhibits those containing an NR2D subunit. PREGAS negatively regulates all iGluRs. Intrinsic and extrinsic fluorescence studies will be presented that confirm the binding of the NMDA NR2B S1S2 and amino terminal domains (ATD) to both PS and PREGAS. Unlike the NR2B subunit, the NR2D S1S2 domain does not bind to PS and PREGAS, however the NR2D ATD does bind to both neurosteroids. Data from isothermal titration calorimetry and Stern‐Volmer analysis will be presented to help differentiate the binding site of each of these neurosteroids on both the NMDA NR2B and NR2D subunits.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call